- Published at
- by manilatimes.net
mixed
mixed
News for Annexon, Inc. (ANNX)
- Published at
- by gurufocus.com
neutralneutralAnnexon Biosciences to Present at the Jefferies Global Healthcare Conference
BRISBANE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. ( ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therap- Published at
- by manilatimes.net
neutralneutral- Published at
- by gurufocus.com
positivepositiveAnnexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting
First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highligh- Published at
- by gurufocus.com
positivepositiveAnnexon (ANNX) Highlights Promising Results from Tanruprubart Phase 3 Trial | ANNX Stock News
Annexon (ANNX) showcased promising findings from its Phase 3 trial of tanruprubart at the 2025 Peripheral Nerve Society annual meeting in Edinburgh, UK. These r- Published at
- by manilatimes.net
mixedmixed- Published at
- by manilatimes.net
neutralneutral- Published at
- by benzinga.com
positivepositiveCoinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday - Annexon (NASDAQ:ANNX), Camtek (NASDAQ:CAMT)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...- Published at
- by benzinga.com
positivepositiveStanley Black & Decker To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday - Affimed (NASDAQ:AFMD), Annexon (NASDAQ:ANNX)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...- Published at
- by gurufocus.com
positivepositiveAnnexon Inc Reports Q1 2025 EPS of -$0.37, Missing Estimates; Revenue at $0.00 Million
Net Loss: Reported a net loss of $54.4 million or $0.37 per share for Q1 2025, compared to a net loss of $25.2 million or $0.21 per share in Q1 2024.Earnings P- Published at
- by manilatimes.net
neutralneutral- Published at
- by finance.yahoo.com
mixedmixedWhy Annexon Inc. (ANNX) Went Down On Thursday?
We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where Annexon Inc. (NASDAQ:ANNX) stands against other stocks that fall behind amid market optimism. Wall Street’s main indices rebounded from hefty losses on Wednesday after President Donald Trump announced that the […]- Published at
- by gurufocus.com
neutralneutralAnnexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. ( ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel ther- Published at
- by seekingalpha.com
positivepositiveAnnexon: Despite Major Catalysts, Stock Is Trading Almost At Cash (NASDAQ:ANNX)
Annexon's ANX005 shows promise for Guillain-Barre treatment with strong phase 3 results. Click here to read an analysis of ANNX stock now.- Published at
- by gurufocus.com
neutralneutralAnnexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones
Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting Targeted for 1H 202- Published at
- by gurufocus.com
neutralneutralAnnexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference
BRISBANE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. ( ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel thera- Published at
- by gurufocus.com
neutralneutralAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. ( ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel thera- Published at
- by manilatimes.net
negativenegative- Published at
- by gurufocus.com
positivepositiveVanguard Group Inc's Strategic Acquisition of Annexon Inc Shares
On December 31, 2024, Vanguard Group Inc executed a significant transaction by acquiring an additional 576,625 shares of Annexon Inc at a price of $5.13 per sha- Published at
- by gurufocus.com
positivepositiveAnnexon Expands Board of Directors with Appointment of Commercial Executive William “BJ” Jones
Seasoned biotechnology industry leadership spanning three decades across U.S. and global commercial operations BRISBANE, Calif., Jan. 10, 2025 (GLOBE NEWSWI